Key facts
- This page summarizes Virgil Thompson's Form 4 filing for Processa Pharmaceuticals, Inc. (PCSA).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 24 Jul 2023, 18:33.
Virgil Thompson - 27 Jun 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)
- Reporting relationship
- Director
- Issuer ticker
- PCSA
- Reported as of
- 27 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Jul 2023, 18:33:29 UTC
- Prior SEC filing
- 04 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Virgil Thompson by Michael B. Kirwan, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Virgil Thompson filed Form 4 for Processa Pharmaceuticals, Inc. (PCSA) on 24 Jul 2023.
Change
- Previous filing in this sequence was filed on 04 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCSA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +23,636
- Change %
- +24%
- Price
- Shares after
- 123,849
- Date
- 27 Jun 2023
- Ownership
- By Thompson Family Trus
- Footnotes
- F1
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 16,693
- Date
- 27 Jun 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCSA
transaction
Derivative
Restricted Stock
Options Exercise
- Transaction value
- $0
- Shares
- -23,636
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 27 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,636
- Exercise price
- $0.000000
- Footnotes
- F1
PCSA
transaction
Derivative
Restricted Stock
Award
- Transaction value
- $0
- Shares
- +101,365
- Change %
- Price
- $0.000000
- Shares after
- 101,365
- Date
- 27 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 101,365
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Vesting of time-based restricted shares.
Footnote F2
The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.